Fig. 3From: Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agentsScatter plot of predicted pGI50 versus the actual pGI50 for the reported modelBack to article page